Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

10.25
Delayed Data
As of Aug 26
 +0.05 / +0.49%
Today’s Change
4.37
Today|||52-Week Range
10.85
+64.00%
Year-to-Date
No recent news for ARIAD Pharmaceuticals Inc.

Today’s Trading

Previous close10.20
Today’s open10.16
Day’s range10.03 - 10.34
Volume4,056,394
Average volume (3 months)4,702,415
Market cap$2.0B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+93.60%
Earnings growth (next 5 years)+41.39%
Revenue growth (last year)+12.70%
P/E ratioNM
Price/Sales9.93
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc+0.31+4.51%
BLUEbluebird bio Inc+1.26+2.52%
EXASExact Sciences Corp+0.14+0.73%
OPHTOphthotech Corp+1.02+1.95%
Data as of 3:59pm ET, 08/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$118.8M
Annual profit (last year)-$231.2M
Net profit margin-194.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paris Panayiotopoulos
Chief Financial Officer, Treasurer &
Executive VP
Manmeet Singh Soni
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs